GEORGE EVANS: Open Payments
NPI 1124073788 · SHEFFIELD, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,939 in 113 payments from 22 companies in 2025. Trend: 2023 $1,667 · 2024 $2,402 · 2025 $1,939
Food & beverage: $1,939
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $427 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 20 | $243 |
| ABBVIE INC. | 31 | $237 |
| Axsome Therapeutics, Inc. | 8 | $149 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $139 |
| Dexcom, Inc. | 1 | $125 |
| Kowa Pharmaceuticals America, Inc. | 1 | $114 |
| PFIZER INC. | 6 | $91 |
| Novo Nordisk Inc | 4 | $66 |
| Phathom Pharmaceuticals, Inc. | 3 | $46 |
Products named: AIRSUPRA, RELISTOR, CAPLYTA, DEXCOM G7 GSS (161), QULIPTA, BREZTRI, ZORYVE, Auvelity.
Industry payments across AL — which companies pay providers there.
